Merck KGaA (OTCMKTS:MKGAF – Get Free Report) traded down 4% during mid-day trading on Monday . The stock traded as low as $162.22 and last traded at $162.22. 108 shares were traded during mid-day trading, a decline of 83% from the average session volume of 625 shares. The stock had previously closed at $168.90.
Merck KGaA Trading Up 3.4%
The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The stock has a market cap of $22.05 billion, a price-to-earnings ratio of 26.05 and a beta of 0.96. The company’s fifty day moving average is $160.67 and its two-hundred day moving average is $147.40.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Palantir Soars 30% After Blockbuster Earnings—Is the Rally Just Getting Started?
- Visa’s BioCatch Deal Could Make Fraud Prevention a Bigger Business
- Caterpillar’s Record Quarter May Have Reset the Stock’s Ceiling
- The Real Reason Amazon Hit a $3 Trillion Valuation
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
